Independent Editorial Rankings
We independently rank GLP-1 telehealth providers, weight loss programs, and the pharmacies behind them — so you can save money without falling for sketchy ads.
Reader-supported. When you sign up with a provider through our links we may earn a commission at no extra cost to you. How we make money.
Why readers use us
Brand-name Wegovy retails for around $1,349/month without insurance. The median compounded semaglutide provider in our dataset charges $174/month— same active ingredient, same weekly injection, a fraction of the cost.
Cheapest first-month rate currently in our dataset: $0/mo. Introductory pricing varies by provider and typically increases after the first month — always verify on the provider's site before signing up.
Quick Match
Three questions. We'll instantly show you the highest-rated provider that matches your budget, state, and preference — based on real pricing data.
Top Rated
Best for lowest first-month entry pricing on compounded GLP-1s
“Lowest first-month entry pricing in the compounded segment ($99 first month for semaglutide, $149 for tirzepatide injection)”
Best for patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Best for lab-monitored compounded GLP-1 with mandatory video visit
Every provider in our dataset has a first-party editorial review with a six-dimension score, verified pricing, state coverage, and primary-source citations. Read what we found before signing up.
Use our savings calculator to see what you could pay — then compare providers side by side to find the best deal.
Interactive pharmacokinetic simulator showing how semaglutide, tirzepatide, and Foundayo (orforglipron) build up across the standard FDA titration schedule.
6-drug interactive timeline showing when nausea peaks, when it resolves, and what every other GLP-1 side effect looks like by week. Every cell anchored to a primary source.
Coverage Map
Click any state to see the providers that ship and prescribe there. Darker squares mean more provider options available.
Coverage data compiled from 460 GLP-1 telehealth providers tracked by Weight Loss Rankings.
Editorial flagship
Primary-source deep-dives on GLP-1 weight-loss medications, every claim cited from FDA prescribing information and PubMed.
What 'Ozempic legs' actually are — subcutaneous fat loss, lean-mass reduction, and loose/saggy skin that make legs look thinner, older, hollow, or veiny after GLP-1 weight loss — who's most at risk, and how to prevent and manage it.
Read the analysis→How to know if Ozempic is working — the early signs that appear in the first 1–2 weeks (reduced food noise, earlier satiety, smaller portions, mild GI effects) and what meaningful weight loss actually looks like as the dose titrates up.
Read the analysis→Muscle cramps on Ozempic are not a direct GLP-1 effect. The credible mechanism is secondary: reduced intake, GI fluid losses (vomiting, diarrhea), and rapid weight loss shift electrolytes. Evidence, honest framing, and what helps.
Read the analysis→A clinician-informed 7-day plan, protein & fiber targets, food lists, and a grocery list — sent straight to your inbox.